SureTrader
Home > Boards > US Listed > Medical - Equipment > Navidea Biopharmaceuticals, Inc. (NAVB)

$120 per share for NAVB? Let the

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
casperboo Member Profile
 
Followed By 6
Posts 1,168
Boards Moderated 0
Alias Born 02/13/10
160x600 placeholder
Advertisement
3 Biotech Stocks with Low Liquidity Ratios -- Are They in Trouble? "The Motley Fool" - 6/29/2015 9:03:02 AM
Navidea Biopharmaceuticals to Present at JMP Life Sciences Conference "Business Wire" - 6/17/2015 9:11:00 AM
Macrophage Therapeutics to Present at BIO2015 Conference "Business Wire" - 6/15/2015 7:30:00 AM
BIND Therapeutics & Macrophage Therapeutics Announce Collaboration to Engineer CD206 Targeted Accurin™ Nanoparticle Using M... "Business Wire" - 6/11/2015 8:00:00 AM
Navidea Reports Manocept™ Study Results in Rheumatoid Arthritis Presented at EULAR 2015 European Congress of Rheumatology "Business Wire" - 6/11/2015 7:30:00 AM
Navidea Reports Positive Lymphoseek® Comparative Results in Injection Site Pain Study in Breast Cancer "Business Wire" - 6/8/2015 4:30:00 PM
Proxy Statement (definitive) (def 14a) "Edgar (US Regulatory)" - 6/5/2015 11:46:55 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/4/2015 4:09:48 PM
Initial Statement of Beneficial Ownership (3) "Edgar (US Regulatory)" - 6/4/2015 3:13:42 PM
Navidea to Report Manocept™ Results in Kaposi’s Sarcoma at the International Workshop on KSHV and Related Agents "Business Wire" - 6/4/2015 12:51:00 PM
Navidea Biopharmaceuticals Appoints Anton Gueth to Board of Directors "Business Wire" - 6/4/2015 7:30:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/2/2015 4:52:15 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/1/2015 12:36:12 PM
Amended Statement of Changes in Beneficial Ownership (4/a) "Edgar (US Regulatory)" - 6/1/2015 12:31:39 PM
Specialized Disclosure Report (sd) "Edgar (US Regulatory)" - 5/29/2015 11:15:20 AM
Navidea Biopharmaceuticals to Present at Jefferies Global Healthcare Conference "Business Wire" - 5/26/2015 12:25:00 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/26/2015 10:18:01 AM
Amended Current Report Filing (8-k/a) "Edgar (US Regulatory)" - 5/21/2015 4:33:08 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/15/2015 4:14:45 PM
Navidea Reports First Quarter 2015 Financial Results; Reiterates 2015 Lymphoseek® Revenue Guidance "Business Wire" - 5/12/2015 7:30:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 5/11/2015 5:53:30 PM
Navidea Secures $60 Million Loan with CRG; Funding to Support Lymphoseek® Commercialization & Advancement of Development Pip... "Business Wire" - 5/11/2015 4:29:00 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/5/2015 5:08:28 PM
Navidea Biopharmaceuticals Stock Rating Reaffirmed by Zacks (NAVB) "Analyst Ratings Network" - 5/1/2015 4:34:35 PM
Navidea Biopharmaceuticals to Announce First Quarter 2015 Financial Results on May 12, 2015 "Business Wire" - 4/30/2015 12:31:00 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist